Arbutus Biopharma Eulerpool News

Arbutus Biopharma Aktie News

Arbutus Biopharma wird von vielen Journalisten und Investoren weltweit beobachtet. Die aktuellsten Arbutus Biopharma News stellen wir hier zusammen.

• 4. Juni ·

  SeekingAlpha
  Tourlite Capital Q1 2025 Investor Letter
• 31. Mai ·

  SeekingAlpha
  abrdn Life Sciences Investors Q1 2025 Commentary
• 14. Mai ·

  Yahoo
  Arbutus Biopharma (ABUS) Reports Q1 Loss, Tops Revenue Estimates
• 13. Mai ·

  Yahoo
  Is Editas Medicine (EDIT) Stock Outpacing Its Medical Peers This Year?
• 7. Mai ·

  Yahoo
  Arbutus Presents Clinical Trial Data from its Two HBV Assets, Imdusiran and AB-101, at the European Association for the Study of the Liver (EASL) Congress 2025
• 25. April ·

  Yahoo
  Is Boston Scientific (BSX) Stock Outpacing Its Medical Peers This Year?
• 23. April ·

  Yahoo
  Arbutus to Present Imdusiran and AB-101 Data at EASL Congress 2025
• 31. März ·

  Yahoo
  All You Need to Know About Arbutus (ABUS) Rating Upgrade to Buy
• 31. März ·

  Yahoo
  Is Arbutus Biopharma (ABUS) Outperforming Other Medical Stocks This Year?
• 28. März ·

  Yahoo
  Novo gains Lexicon obesity drug; CRISPR COO to step down